A detailed history of Pasadena Private Wealth, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Pasadena Private Wealth, LLC holds 785 shares of LLY stock, worth $624,600. This represents 0.16% of its overall portfolio holdings.

Number of Shares
785
Previous 791 0.76%
Holding current value
$624,600
Previous $716,000 2.93%
% of portfolio
0.16%
Previous 0.17%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$772.14 - $960.02 $4,632 - $5,760
-6 Reduced 0.76%
785 $695,000
Q2 2024

Jul 19, 2024

BUY
$724.87 - $909.04 $7,248 - $9,090
10 Added 1.28%
791 $716,000
Q3 2023

Oct 10, 2023

BUY
$434.7 - $599.3 $13,041 - $17,979
30 Added 3.99%
781 $419,000
Q4 2022

Feb 02, 2023

SELL
$321.55 - $374.67 $7,717 - $8,992
-24 Reduced 3.1%
751 $274,000
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $174,258 - $216,256
775 New
775 $214,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Pasadena Private Wealth, LLC Portfolio

Follow Pasadena Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pasadena Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pasadena Private Wealth, LLC with notifications on news.